Your browser doesn't support javascript.
loading
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel, Tania; Giglhuber, Katrin; Aktas, Orhan; Ayzenberg, Ilya; Bellmann-Strobl, Judith; Häußler, Vivien; Havla, Joachim; Hellwig, Kerstin; Hümmert, Martin W; Jarius, Sven; Kleiter, Ingo; Klotz, Luisa; Krumbholz, Markus; Paul, Friedemann; Ringelstein, Marius; Ruprecht, Klemens; Senel, Makbule; Stellmann, Jan-Patrick; Bergh, Florian Then; Trebst, Corinna; Tumani, Hayrettin; Warnke, Clemens; Wildemann, Brigitte; Berthele, Achim.
Afiliación
  • Kümpfel T; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians-Universität München, Munich, Germany. Tania.Kuempfel@med.uni-muenchen.de.
  • Giglhuber K; Department of Neurology, School of Medicine, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany.
  • Aktas O; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Ayzenberg I; Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
  • Bellmann-Strobl J; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Häußler V; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Havla J; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Hellwig K; NeuroCure Clinical Research Center, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, and Berlin Institute of Health, and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Hümmert MW; Department of Neurology and Institute of Neuroimmunology and MS (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Jarius S; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Kleiter I; Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
  • Klotz L; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Krumbholz M; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Paul F; Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
  • Ringelstein M; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany.
  • Ruprecht K; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Senel M; Department of Neurology and Pain Treatment, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.
  • Stellmann JP; Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.
  • Bergh FT; Department of Neurology & Stroke, University Hospital of Tübingen, Tübingen, Germany.
  • Trebst C; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Tumani H; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Warnke C; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Wildemann B; NeuroCure Clinical Research Center, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, and Berlin Institute of Health, and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Berthele A; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
J Neurol ; 271(1): 141-176, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37676297
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neuromielitis Óptica Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Neurol Año: 2024 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neuromielitis Óptica Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Neurol Año: 2024 Tipo del documento: Article País de afiliación: Alemania